BVB RON

Antibiotice S.A. (ATB.RO)

1.8000
+0.0120
+(0.67%)
At close: May 16 at 5:53:27 PM GMT+3
Loading Chart for ATB.RO
  • Previous Close 1.7880
  • Open 1.8000
  • Bid 1.7960 x --
  • Ask 1.8000 x --
  • Day's Range 1.7800 - 1.8200
  • 52 Week Range 1.7500 - 3.4400
  • Volume 331,561
  • Avg. Volume 203,821
  • Market Cap (intraday) 1.208B
  • Beta (5Y Monthly) 0.09
  • PE Ratio (TTM) 12.00
  • EPS (TTM) 0.1500
  • Earnings Date --
  • Forward Dividend & Yield 0.02 (1.14%)
  • Ex-Dividend Date Sep 25, 2025
  • 1y Target Est 2.66

Antibiotice S.A. produces and sells medicinal products in Romania. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; and veterinary medicines. Its products are available in the form of sterile injectable powders, capsules, tablets, ointments, gels, creams, and suppositories. It also provides active pharmaceutical ingredients. In addition, the company exports its products worldwide. Antibiotice S.A. was founded in 1955 and is headquartered in Iasi, Romania.

www.antibiotice.ro

1,355

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ATB.RO

View More

Performance Overview: ATB.RO

Trailing total returns as of 5/18/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

ATB.RO
29.69%
MSCI WORLD (^990100-USD-STRD)
4.19%

1-Year Return

ATB.RO
7.09%
MSCI WORLD (^990100-USD-STRD)
11.25%

3-Year Return

ATB.RO
251.52%
MSCI WORLD (^990100-USD-STRD)
44.96%

5-Year Return

ATB.RO
276.76%
MSCI WORLD (^990100-USD-STRD)
86.72%

Compare To: ATB.RO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ATB.RO

View More

Valuation Measures

As of 5/16/2025
  • Market Cap

    1.21B

  • Enterprise Value

    1.35B

  • Trailing P/E

    11.83

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.79

  • Price/Book (mrq)

    1.35

  • Enterprise Value/Revenue

    1.99

  • Enterprise Value/EBITDA

    8.82

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.84%

  • Return on Assets (ttm)

    5.54%

  • Return on Equity (ttm)

    11.74%

  • Revenue (ttm)

    688.7M

  • Net Income Avi to Common (ttm)

    102.2M

  • Diluted EPS (ttm)

    0.1500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.68M

  • Total Debt/Equity (mrq)

    16.02%

  • Levered Free Cash Flow (ttm)

    -60.04M

Research Analysis: ATB.RO

View More

People Also Watch